COO - The Cooper Companies, Inc.
NEXT EARNINGS:
Mar 5, 2026
(in 8 days)
EPS Est: $1.03
|
Rev Est: $1.0B
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$91.63
DETAILS
HIGH:
$100.00
LOW:
$73.00
MEDIAN:
$96.50
CONSENSUS:
$91.63
UPSIDE:
9.66%
Market Cap:
16.61B
Volume:
1,580,447
Avg Volume:
2,532,316
52 Week Range:
61.78-92.84
Sector:
Healthcare
Industry:
Medical - Instruments & Supplies
Beta:
1.03
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
16,000
IPO Date:
1983-01-21
EPS (TTM):
1.88
P/E Ratio:
37.30
Revenue (TTM):
4.09B
Total Assets:
12.39B
Total Debt:
2.78B
Cash & Equiv:
110.60M
Rev Growth (5Y):
11.0%
EPS Growth (5Y):
-17.3%
FCF Growth (5Y):
19.7%
ROCE:
5.6%
Debt/Equity:
0.34
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-12-04 | $1.15 | $1.11 | +3.6% | $1.1B | $1.1B | +0.4% |
| 2025-08-27 | $1.10 | $1.07 | +2.8% | $1.1B | $1.1B | -0.3% |
| 2025-05-29 | $0.96 | $0.93 | +3.4% | $1.0B | $995.3M | +0.7% |
| 2025-03-06 | $0.92 | $0.91 | +0.7% | $964.7M | $978.1M | -1.4% |
| 2024-12-05 | $1.04 | $1.00 | +4.0% | $1.0B | $1.0B | -0.8% |
| 2024-08-28 | $0.96 | $0.91 | +5.4% | $1.0B | $997.3M | +0.6% |
| 2024-05-30 | $0.85 | $0.83 | +2.5% | $942.6M | $948.1M | -0.6% |
| 2024-02-29 | $0.85 | $0.78 | +8.6% | $931.6M | $915.9M | +1.7% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.09B | 3.90B | 3.59B | 3.31B | 2.92B | 2.43B | 2.65B | 2.53B | 2.14B | 1.97B | 1.80B | 1.72B |
| Net Income | 374.90M | 392.30M | 294.20M | 385.80M | 2.94B | 238.40M | 466.70M | 139.90M | 372.90M | 273.92M | 203.52M | 269.86M |
| EPS | 1.88 | 1.97 | 1.49 | 1.96 | 59.73 | 4.86 | 9.47 | 2.85 | 7.63 | 5.65 | 4.20 | 5.61 |
| Total Assets | 12.39B | 12.32B | 11.66B | 11.49B | 9.61B | 6.74B | 6.27B | 6.11B | 4.86B | 4.48B | 4.46B | 4.46B |
| Total Debt | 2.78B | 2.58B | 2.57B | 2.76B | 1.48B | 2.06B | 1.83B | 2.02B | 1.17B | 1.33B | 1.35B | 1.38B |
| Cash & Equivalents | 110.60M | 107.60M | 120.80M | 138.20M | 95.90M | 115.90M | 89.00M | 77.70M | 88.80M | 100.80M | 16.43M | 25.22M |
| Operating Cash Flow | 796.10M | 709.30M | 607.50M | 692.40M | 738.60M | 486.60M | 713.20M | 668.90M | 593.60M | 509.60M | 390.97M | 454.82M |
| Free Cash Flow | 433.70M | 288.10M | 215.00M | 450.40M | 524.20M | 176.20M | 421.10M | 475.30M | 466.40M | 357.00M | 147.95M | 216.76M |
| FCF per Share | 2.17 | 1.45 | 1.09 | 2.28 | 2.66 | 0.90 | 2.14 | 2.42 | 2.38 | 1.84 | 3.05 | 4.51 |
| Book Value | 8.24B | 8.08B | 7.55B | 7.17B | 6.94B | 3.82B | 3.63B | 3.31B | 3.18B | 2.70B | 2.67B | 2.57B |
| Cash & ST Investments | 110.60M | 107.60M | 120.80M | 138.20M | 95.90M | 115.90M | 89.00M | 77.70M | 88.80M | 100.80M | 16.43M | 25.22M |
| ROC Equity | 0.05 | 0.05 | 0.04 | 0.05 | 0.42 | 0.06 | 0.13 | 0.04 | 0.12 | 0.10 | 0.08 | 0.11 |